Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

GL-701 shows significant steroid-sparing effects in women with active SLE

Nov. 20, 1997

Synvisc introduced in U.S.

Nov. 20, 1997

Preliminary phase III data presented on celecoxib at arthritis symposium

Nov. 20, 1997

Enbrel phase III and long-term safety data presented at rheumatology meeting

Nov. 20, 1997

New VCAM-1 inhibitor isolated from marine sponge

Nov. 19, 1997

rhIL-11 effective in rats with adjuvant arthritis

Nov. 19, 1997

rhIL-10 evaluated for safety and efficacy in RA patients

Nov. 19, 1997

Complement activation inhibitors prepared at U of Pennsylvania

Nov. 19, 1997

Second-generation, highly selective COX-2 inhibitors developed at Merck

Nov. 18, 1997

Safety, immunogenicity and efficacy of anti-TNF antibody in RA patients

Nov. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.